Impact of Body Mass Index Variability on Kidney Disease Progression in a Large Type 1 Diabetes Cohort
Diabetes/Metabolism Research and Reviews · 2026-03 · 42 (3)
DOI: 10.1002/dmrr.70148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes/Metabolism Research and Reviews, online erschienen am 19.03.2026. Verfasst von Murat Ozdede und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, UK. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Body Mass Index, Diabetic Nephropathies, Biomarkers. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guy's and St Thomas' Charity.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
Body mass index (BMI) variability an index of ‘metabolic cycling’ predicts kidney disease in type 2 diabetes, but studies in people with type 1 diabetes (pwT1DM) are scarce. We examined the relationship between BMI variability and diabetic kidney disease (DKD) progression in an ethnically diverse cohort of pwT1DM.
Methods
We analysed 3270 pwT1DM (52% female, 80% white) with baseline eGFR ≥ 45 mL/min/1.73 m 2 and ≥ 6 BMI measurements, attending two university hospital clinics (between 2004 and 2018). BMI variability was assessed using standard deviation (SD), visit‐adjusted SD, variability independent of the mean (VIM), and average real variability (ARV). The primary endpoint was ≥ 50% eGFR decline with final eGFR < 30 mL/min/1.73 m 2 . Multivariable and competing risk analyses (with mortality as competing risk) were performed.
Results
Over a median of 9.6 years, 179 (5.5%) people reached the primary endpoint. Those who reached the primary endpoint had higher BMI variability, with baseline higher age, HbA1c, systolic blood pressure, albuminuria levels, and were more often of African‐Carribean ethnicity as compared to those who did not. In multivariable models and competing risk analyses, all BMI variability indices were independent risk‐factors for the primary endpoint. Visit‐adjusted SD (HR 2.43, 95% CI 1.93–3.05) and ARV (HR 1.7, 95% CI 1.44–2.01) were the strongest BMI variability indices associated with the primary endpoint.
Conclusion
BMI variability is an independent predictor of DKD progression in pwT1DM. Further studies are required to elucidate the underlying mechanisms of our observations and explore if addressing BMI variability can translate to clinical benefits in DKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, UK.
ORCID-Profile: Panagiotis Pavlou, Janaka Karalliedde
Förderung
- Guy's and St Thomas' Charity
Zitieren
APA
Ozdede, M., Pavlou, P., Avataneo, M., Thomas, S., Ayis, S., & Karalliedde, J. (2026). Impact of Body Mass Index Variability on Kidney Disease Progression in a Large Type 1 Diabetes Cohort. Diabetes/Metabolism Research and Reviews, 42(3). https://doi.org/10.1002/dmrr.70148
Vancouver
Ozdede M, Pavlou P, Avataneo M, Thomas S, Ayis S, Karalliedde J. Impact of Body Mass Index Variability on Kidney Disease Progression in a Large Type 1 Diabetes Cohort. Diabetes/Metabolism Research and Reviews. 2026;42(3). doi:10.1002/dmrr.70148
BibTeX
@article{Ozdede2026,
author = {Ozdede, Murat and Pavlou, Panagiotis and Avataneo, Marta and Thomas, Stephen and Ayis, Salma and Karalliedde, Janaka},
title = {Impact of Body Mass Index Variability on Kidney Disease Progression in a Large Type 1 Diabetes Cohort},
journal = {Diabetes/Metabolism Research and Reviews},
year = {2026},
volume = {42},
number = {3},
doi = {10.1002/dmrr.70148}
}
EUVIMED